Bangkok Dusit Medical Services Public Company Limited
BDUUF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $107,867,221 | $100,852,576 | $91,933,635 | $74,451,346 |
| % Growth | 7% | 9.7% | 23.5% | – |
| Cost of Goods Sold | $68,070,791 | $63,412,108 | $58,329,375 | $49,461,960 |
| Gross Profit | $39,796,430 | $37,440,468 | $33,604,259 | $24,989,386 |
| % Margin | 36.9% | 37.1% | 36.6% | 33.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $20,828,112 | $19,805,964 | $17,654,572 | $15,028,623 |
| SG&A Expenses | $20,828,112 | $19,805,964 | $17,654,572 | $15,028,623 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$1,545,587 | -$1,301,219 | $0 | $0 |
| Operating Expenses | $19,282,525 | $18,504,745 | $16,620,559 | $13,766,006 |
| Operating Income | $20,513,905 | $18,935,723 | $16,991,807 | $11,227,955 |
| % Margin | 19% | 18.8% | 18.5% | 15.1% |
| Other Income/Exp. Net | -$182,600 | -$283,725 | -$510,424 | -$634,206 |
| Pre-Tax Income | $20,331,304 | $18,651,999 | $16,481,382 | $10,593,750 |
| Tax Expense | $3,792,162 | $3,754,547 | $3,227,151 | $2,103,372 |
| Net Income | $15,987,010 | $14,375,267 | $12,606,203 | $7,936,077 |
| % Margin | 14.8% | 14.3% | 13.7% | 10.7% |
| EPS | 1.01 | 0.9 | 0.79 | 0.5 |
| % Growth | 12.2% | 13.9% | 58% | – |
| EPS Diluted | 1.01 | 0.9 | 0.79 | 0.5 |
| Weighted Avg Shares Out | 15,892,002 | 15,892,002 | 15,892,002 | 15,892,002 |
| Weighted Avg Shares Out Dil | 15,892,002 | 15,892,002 | 15,892,002 | 15,892,002 |
| Supplemental Information | – | – | – | – |
| Interest Income | $174,805 | $173,474 | $79,822 | $73,143 |
| Interest Expense | $433,386 | $546,592 | $632,065 | $728,461 |
| Depreciation & Amortization | $6,131,728 | $5,848,045 | $5,950,000 | $6,321,000 |
| EBITDA | $26,896,418 | $25,046,635 | $23,063,076 | $17,643,505 |
| % Margin | 24.9% | 24.8% | 25.1% | 23.7% |